Cambridge, MA, United States of America

Wei Zhang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 169(Granted Patents)


Location History:

  • Wayne, PA (US) (2011)
  • Cambridge, MA (US) (2008 - 2012)
  • Somerville, MA (US) (2012 - 2013)
  • Philadelphia, PA (US) (2015)

Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Inventor Wei Zhang: Innovations in Pharmacological Compounds**

Introduction

Wei Zhang is a notable inventor based in Somerville, MA, recognized for his significant contributions to the field of pharmacology. With a total of two patents to his name, his work focuses on developing novel compounds that hold therapeutic potential. His ingenuity sets a strong foundation for advancements in medicinal chemistry.

Latest Patents

Zhang's latest inventions include:

1. **Cyclohexane derivatives and uses thereof**

This invention presents a novel compound represented by Formula I. It details a method for manufacturing these compounds, alongside their therapeutic applications. Additionally, it introduces a combination of pharmacologically active agents and a pharmaceutical composition that enhances treatment efficacy.

2. **Furopyridine compounds and uses thereof**

Similarly, Zhang's work on furopyridine compounds provides a compound of Formula I, outlining a method for their production and therapeutic uses. This patent also offers insight into combinations of pharmacologically active agents and pharmaceutical compositions tailored for effective treatment.

Career Highlights

Wei Zhang is currently associated with Novartis AG, a leading global healthcare company. His expertise in pharmaceutical innovations contributes significantly to the development of new therapeutic agents designed to improve patient outcomes. His dedication to research and development within the company positions him as a key player in the field.

Collaborations

Throughout his career, Zhang has collaborated with esteemed colleagues such as David Weninger Barnes and Scott Louis Cohen. These partnerships have fostered a fruitful environment for sharing ideas and advancing research in pharmacological applications, ultimately enhancing the quality and reach of their innovations.

Conclusion

In summary, Wei Zhang’s contributions to pharmacology through his innovative patents on cyclohexane and furopyridine compounds reflect his commitment to advancing medical science. As a vital member of Novartis AG, his work exemplifies the intersection of creativity and science, driving forward the development of new therapeutic solutions. His collaborations with other accomplished professionals further demonstrate the importance of teamwork in achieving meaningful innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…